CORRECTION: Biogen Raises FY2026 Adj EPS Guidance from $15.25-$16.25 to $15.85-$16.85 vs $12.83 Est
Biogen (NASDAQ: BIIB ) raises FY2026 Adj EPS guidance from $15.25-$16.25 to $15.85-$16.85 vs $12.83 analyst estimate..
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.